...
首页> 外文期刊>Neurologia medico-chirurgica. >Japanese Registry of Neuroendovascular therapy: Extracranial steno-occlusive diseases except for internal carotid artery stenosis
【24h】

Japanese Registry of Neuroendovascular therapy: Extracranial steno-occlusive diseases except for internal carotid artery stenosis

机译:日本神经内血管治疗注册机构:颅内狭窄闭塞性疾病,颈内动脉狭窄除外

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Although utilization of endovascular treatment of extracranial steno-occlusive lesions except for internal carotid artery stenosis continues to increase, there is no consensus regarding the natural course and standard treatment of these lesions. The aim of this study was to characterize the utility of endovascular treatment for extracranial steno-occlusive lesions except for internal carotid artery stenosis. A total of 1249 procedures for extracranial steno-occlusive lesions were identified from the Japanese Registry of Neuroendovascular Therapy (JR-NET) and JR-NET2. Excluding the cases of carotid lesions (290 cases), endovascular procedures were performed for 471 (37.7%) subclavian artery stenoses, 404 (32.3%) extracranial vertebral artery stenoses, and 38 (3.0%) innominate artery stenoses with a technical success rate of 97.2%. A stent was placed for 783 lesions and percutaneous transluminal angioplasty was performed for 183 lesions. Forty complications were reported in this cohort. Among these, ischemic complications were the most frequent (12 cases). Comparison between JR-NET1 and JR-NET2 demonstrated a marked increase in the number of procedures, a change in the utilization of antiplatelet therapy, and an increased rate of favorable outcome. We conclude that the endovascular treatment for extracranial steno-occlusive lesions is relatively safe. Continuous efforts should be made to reduce the complication rate, and further trials are needed to validate the beneficial effect of this procedure.
机译:尽管除了颈内动脉狭窄以外,颅内狭窄闭塞性病变的血管内治疗的利用继续增加,但是对于这些病变的自然病程和标准治疗尚无共识。这项研究的目的是表征除颈内动脉狭窄外,颅内狭窄闭塞性病变的血管内治疗的实用性。从日本神经内血管治疗注册中心(JR-NET)和JR-NET2总共鉴定出了1249例颅外狭窄闭塞性病变的手术。不包括颈动脉病变的病例(290例),对471例(37.7%)的锁骨下动脉狭窄,404例(32.3%)的颅外椎动脉狭窄和38例(3.0%)无名动脉狭窄进行了腔内手术,技术成功率为97.2%。放置了783个病变的支架,并进行了183个病变的经皮腔内血管成形术。该队列报道了40例并发症。其中,缺血性并发症最为常见(12例)。对JR-NET1和JR-NET2的比较表明,程序数量显着增加,抗血小板治疗的使用发生了变化,并且有利结果的发生率增加。我们得出的结论是,颅外狭窄闭塞性病变的血管内治疗相对安全。应该不断努力降低并发症发生率,并且需要进一步的试验来验证该手术的有益效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号